Alan Scharfstein, president and CEO of the DAK Group, discusses how his firm facilitated Trane’s purchase of Calmac, intangibles firms should consider before buying, and how to make the most out of a sale.
The BVH team’s capabilities and portfolio complement Salas O’Brien’s existing work in New England, particularly with large higher education, healthcare, and other mission-critical facilities.